Duopharma Biotech Bhd
KLSE:DPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
MY |
|
E
|
Engtex Group Bhd
KLSE:ENGTEX
|
MY |
|
E
|
Evd Bhd
KLSE:EVD
|
MY |
|
I
|
Infrastrutture Wireless Italiane SpA
F:WI8
|
IT |
|
OceanFirst Financial Corp
NASDAQ:OCFC
|
US |
|
F
|
FrieslandCampina Engro Pakistan Ltd
KAR:FCEPL
|
PK |
|
K
|
Kelly Services Inc
NASDAQ:KELYB
|
US |
|
Neometals Ltd
ASX:NMT
|
AU |
|
Pulmuone Co Ltd
KRX:017810
|
KR |
|
Cerus Corp
NASDAQ:CERS
|
US |
|
Flameret Inc
OTC:FLRE
|
US |
|
Piscines Desjoyaux SA
F:DJX
|
FR |
|
I
|
IDIS Holdings Co Ltd
KOSDAQ:054800
|
KR |
|
Var Energi ASA
F:J4V
|
NO |
|
ImExHS Ltd
ASX:IME
|
AU |
|
Agat Ejendomme A/S
CSE:AGAT
|
DK |
|
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
|
US |
|
T
|
Tipco Foods PCL
SET:TIPCO
|
TH |
|
CMX Gold & Silver Corp
OTC:CXXMF
|
CA |
Bankruptcy Probability
Duopharma Biotech Bhd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Duopharma Biotech Bhd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MY |
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
1.1B MYR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
615.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
360.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
193B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
269B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
168.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Duopharma Biotech Bhd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Duopharma Biotech Bhd has total debt of 336.6m MYR. This includes both short-term (0 MYR) and long-term (336.6m MYR) debt.
You can find a full breakdown on its Balance Sheet.